Profile data is unavailable for this security.
About the company
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
- Revenue in CAD (TTM)757.12k
- Net income in CAD-5.48m
- Incorporated2003
- Employees--
- LocationKane Biotech Inc290-100 Innovation DriveWINNIPEG R3T 6G2CanadaCAN
- Phone+1 (204) 453-1301
- Fax+1 (204) 474-7552
- Websitehttps://kanebiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voyageur Pharmaceuticals Ltd | 0.00 | -1.53m | 9.07m | -- | -- | 9.60 | -- | -- | -0.0112 | -0.0112 | 0.00 | 0.0068 | 0.00 | -- | -- | -- | -67.92 | -74.47 | -111.56 | -120.92 | -- | -- | -- | -- | 0.0896 | -329.90 | 0.0406 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
| Khiron Life Sciences Corp | 16.14m | -30.66m | 9.56m | 310.00 | -- | -- | -- | 0.5924 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
| Willow Biosciences Inc | 2.87m | -7.72m | 11.54m | 19.00 | -- | 59.16 | -- | 4.02 | -0.0604 | -0.0604 | 0.0222 | 0.0014 | 0.4901 | -- | 6.33 | 151,000.00 | -131.79 | -- | -193.14 | -- | -- | -- | -268.91 | -- | 0.756 | -- | 0.9002 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Crescita Therapeutics Inc | 17.40m | -2.74m | 11.89m | 80.00 | -- | 0.7406 | -- | 0.6833 | -0.1409 | -0.1409 | 0.8891 | 0.8371 | 0.7243 | 1.29 | 9.27 | 217,537.50 | -11.40 | -0.2457 | -14.88 | -0.3059 | 55.58 | 63.41 | -15.73 | -0.3518 | 1.68 | -- | 0.0545 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
| Kane Biotech Inc | 757.12k | -5.48m | 14.50m | -- | -- | -- | -- | 19.16 | -0.042 | 0.0374 | 0.0059 | -0.0055 | 0.1568 | 0.3751 | 3.23 | -- | -113.43 | -77.89 | -- | -- | 60.54 | 43.27 | -723.31 | -241.85 | 0.5679 | -4.73 | 1.43 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
| Pharmacielo Ltd | 1.62m | -14.15m | 15.82m | 268.00 | -- | -- | -- | 9.76 | -0.0849 | -0.0849 | 0.0097 | -0.032 | 0.0699 | 1.38 | 24.15 | -- | -61.03 | -- | -165.82 | -- | -86.39 | -- | -873.57 | -- | 0.039 | -2.48 | 1.37 | -- | -70.96 | -- | -12.27 | -- | -- | -- |
| Cytophage Technologies Ltd | 0.00 | -7.80m | 17.53m | -- | -- | 3.32 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
| Devonian Health Group Inc | 9.75m | -3.17m | 18.53m | 6.00 | -- | 1.39 | -- | 1.90 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
